
### [NCIT:C4030](http://purl.obolibrary.org/obo/NCIT_C4030)
**Label:** Urothelial Carcinoma

**Subclasses:** [NCIT:C4597](http://purl.obolibrary.org/obo/NCIT_C4597) (Stage 0is Renal Pelvis Urothelial Carcinoma), [NCIT:C4830](http://purl.obolibrary.org/obo/NCIT_C4830) (Ureter Urothelial Carcinoma), [NCIT:C7383](http://purl.obolibrary.org/obo/NCIT_C7383) (Bladder Papillary Urothelial Carcinoma), [NCIT:C39879](http://purl.obolibrary.org/obo/NCIT_C39879) (Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C7517](http://purl.obolibrary.org/obo/NCIT_C7517) (Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C27885](http://purl.obolibrary.org/obo/NCIT_C27885) (Infiltrating Bladder Urothelial Carcinoma), [NCIT:C115966](http://purl.obolibrary.org/obo/NCIT_C115966) (Infiltrating Bladder Urothelial Carcinoma Associated with Urethral Carcinoma), [NCIT:C7716](http://purl.obolibrary.org/obo/NCIT_C7716) (Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C7518](http://purl.obolibrary.org/obo/NCIT_C7518) (Stage 0is Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C6149](http://purl.obolibrary.org/obo/NCIT_C6149) (Stage 0 Ureter Urothelial Carcinoma), [NCIT:C6148](http://purl.obolibrary.org/obo/NCIT_C6148) (Renal Pelvis Papillary Urothelial Carcinoma), [NCIT:C39829](http://purl.obolibrary.org/obo/NCIT_C39829) (Infiltrating Bladder Urothelial Carcinoma with Giant Cells), [NCIT:C7355](http://purl.obolibrary.org/obo/NCIT_C7355) (Renal Pelvis Urothelial Carcinoma), [NCIT:C6188](http://purl.obolibrary.org/obo/NCIT_C6188) (Stage 0 Bladder Urothelial Carcinoma), [NCIT:C8168](http://purl.obolibrary.org/obo/NCIT_C8168) (Regional Urothelial Carcinoma of the Renal Pelvis and Ureter), [NCIT:C8167](http://purl.obolibrary.org/obo/NCIT_C8167) (Localized Urothelial Carcinoma of the Renal Pelvis and Ureter), [NCIT:C6186](http://purl.obolibrary.org/obo/NCIT_C6186) (Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant), [NCIT:C6191](http://purl.obolibrary.org/obo/NCIT_C6191) (Stage I Bladder Urothelial Carcinoma), [NCIT:C39820](http://purl.obolibrary.org/obo/NCIT_C39820) (Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant), [NCIT:C6193](http://purl.obolibrary.org/obo/NCIT_C6193) (Stage 0 Renal Pelvis Urothelial Carcinoma), [NCIT:C39826](http://purl.obolibrary.org/obo/NCIT_C39826) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements), [NCIT:C39825](http://purl.obolibrary.org/obo/NCIT_C39825) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements), [NCIT:C39821](http://purl.obolibrary.org/obo/NCIT_C39821) (Infiltrating Bladder Lymphoepithelioma-Like Carcinoma), [NCIT:C4529](http://purl.obolibrary.org/obo/NCIT_C4529) (Stage 0is Ureter Urothelial Carcinoma), [NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma), [NCIT:C39824](http://purl.obolibrary.org/obo/NCIT_C39824) (Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant), [NCIT:C39819](http://purl.obolibrary.org/obo/NCIT_C39819) (Infiltrating Bladder Urothelial Carcinoma, Nested Variant), [NCIT:C39818](http://purl.obolibrary.org/obo/NCIT_C39818) (Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation), [NCIT:C3644](http://purl.obolibrary.org/obo/NCIT_C3644) (Stage 0is Bladder Urothelial Carcinoma), [NCIT:C6156](http://purl.obolibrary.org/obo/NCIT_C6156) (Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation), [NCIT:C6157](http://purl.obolibrary.org/obo/NCIT_C6157) (Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation), [NCIT:C8254](http://purl.obolibrary.org/obo/NCIT_C8254) (Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter), [NCIT:C27634](http://purl.obolibrary.org/obo/NCIT_C27634) (Transplant-Related Bladder Urothelial Carcinoma), [NCIT:C9267](http://purl.obolibrary.org/obo/NCIT_C9267) (Stage 0a Bladder Urothelial Carcinoma), [NCIT:C27876](http://purl.obolibrary.org/obo/NCIT_C27876) (Non-Invasive Bladder Papillary Urothelial Carcinoma, High Grade), [NCIT:C39851](http://purl.obolibrary.org/obo/NCIT_C39851) (Bladder Urothelial Carcinoma), [NCIT:C39850](http://purl.obolibrary.org/obo/NCIT_C39850) (Stage 0 Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C8064](http://purl.obolibrary.org/obo/NCIT_C8064) (Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter), [NCIT:C39853](http://purl.obolibrary.org/obo/NCIT_C39853) (Infiltrating Urothelial Carcinoma), [NCIT:C126307](http://purl.obolibrary.org/obo/NCIT_C126307) (Recurrent Bladder Urothelial Carcinoma), [NCIT:C126109](http://purl.obolibrary.org/obo/NCIT_C126109) (Metastatic Urothelial Carcinoma), [NCIT:C39817](http://purl.obolibrary.org/obo/NCIT_C39817) (Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation), [NCIT:C39816](http://purl.obolibrary.org/obo/NCIT_C39816) (Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation), [NCIT:C39898](http://purl.obolibrary.org/obo/NCIT_C39898) (Primary Prostate Urothelial Carcinoma), [NCIT:C8939](http://purl.obolibrary.org/obo/NCIT_C8939) (Stage II Bladder Urothelial Carcinoma), [NCIT:C6203](http://purl.obolibrary.org/obo/NCIT_C6203) (Stage 0a Ureter Urothelial Carcinoma), [NCIT:C8940](http://purl.obolibrary.org/obo/NCIT_C8940) (Stage III Bladder Urothelial Carcinoma), [NCIT:C8941](http://purl.obolibrary.org/obo/NCIT_C8941) (Stage IV Bladder Urothelial Carcinoma), [NCIT:C6166](http://purl.obolibrary.org/obo/NCIT_C6166) (Urethral Urothelial Carcinoma), [NCIT:C6202](http://purl.obolibrary.org/obo/NCIT_C6202) (Stage 0a Renal Pelvis Urothelial Carcinoma), [NCIT:C131218](http://purl.obolibrary.org/obo/NCIT_C131218) (Recurrent Urethral Urothelial Carcinoma), [NCIT:C39844](http://purl.obolibrary.org/obo/NCIT_C39844) (Bladder Urachal Urothelial Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) 47.07%
- [NCIT:C36767](http://purl.obolibrary.org/obo/NCIT_C36767) (Abnormal Transitional Cell) 47.07%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40375](http://purl.obolibrary.org/obo/NCIT_C40375) (Breast Diffuse Large B-Cell Lymphoma))) 47.07%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C4037](http://purl.obolibrary.org/obo/NCIT_C4037) (Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome))) 47.07%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40369](http://purl.obolibrary.org/obo/NCIT_C40369) (Sebaceous Breast Carcinoma))) 47.07%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40367](http://purl.obolibrary.org/obo/NCIT_C40367) (Acinic Cell Breast Carcinoma))) 47.07%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40366](http://purl.obolibrary.org/obo/NCIT_C40366) (Oncocytic Breast Carcinoma))) 47.07%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40363](http://purl.obolibrary.org/obo/NCIT_C40363) (Nipple Syringomatous Adenoma))) 47.07%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40362](http://purl.obolibrary.org/obo/NCIT_C40362) (Low Grade Adenosquamous Breast Carcinoma))) 47.07%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40358](http://purl.obolibrary.org/obo/NCIT_C40358) (Squamous Cell Breast Carcinoma, Spindle Cell Variant))) 47.07%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40356](http://purl.obolibrary.org/obo/NCIT_C40356) (Breast Large Cell Neuroendocrine Carcinoma))) 47.07%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40355](http://purl.obolibrary.org/obo/NCIT_C40355) (Breast Columnar Cell Mucinous Carcinoma))) 47.07%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40354](http://purl.obolibrary.org/obo/NCIT_C40354) (Breast Mucinous Cystadenocarcinoma))) 47.07%
- [NCIT:C36768](http://purl.obolibrary.org/obo/NCIT_C36768) (Neoplastic Transitional Cell) and (not ([NCIT:C40350](http://purl.obolibrary.org/obo/NCIT_C40350) (Breast Carcinoma with Choriocarcinomatous Features))) 47.07%


